Abstract
Blood eosinophilia (BE) is occasionally associated with malignant tumors and has been accepted as a marker for disseminated carcinoma with poor prognosis.1,2 Local eosinophilia of the surrounding stroma of a carcinoma also has been reported in various sites, including the head and neck.1,3,4 There has been controversy as to whether tumor-associated tissue eosinophilia (TATE) is indicative of prognosis.5-8 Recently, TATE has been proposed as an indicator of a favorable prognosis.4,9
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
